4 | 5 NOVEMBER
4 | 5 NOVEMBER
Why Cannabiz Summit World?
Investors, medical researchers and policy makers from multiple continents are recognising the world-changing potential of cannabis for medical use. The Production of Cannabis for Medicinal Use Act 2018 was a big step for the future of the industry in Malta.
Join over 2,000 delegates at the inaugural Cannabiz Summit World to discuss legislation, education, investment and technology in this exiting business sector. Showcase your products at the expo and network with top global industry professionals.
November 4th and 5th, the focus is on Malta for the Cannabiz Summit World.
09:00 - 22:00 | Delegates fly to Malta
Beat the queues on Monday morning and collect your badge any time on Sunday from the InterContinental lobby.
19:00 - 22:00 | Welcome Reception
Enjoy a networking head-start with drinks at the InterContinental.
09:00 - 13:00 | Country Focus Workshop | Canada, Malta, United Kingdom, Germany
REGULATION, LEGISLATION & THE ROLE OF BIG PHARMA
09:00 - 09:20 | Malta's Journey
What key drivers were behind the introduction of the production of cannabis for medicinal use act.
09:20 - 09:40 | Research and Development
How has the change in law affected the scientific sector in Malta?
09:40 - 10:00 | The Future of Medical Cannabis
How will a patient-centric approach affect policy and supply chain decisions.
10:00 - 10:20 | WHO and its Impact on National Polotics
International organisations such as the World Health Organisation are becoming increasingly vocal on the application of medical cannabis. How is this impacting policy makers at state-level across different continents?
10:20 - 10:40 | Monitoring and Control
What steps are being taken towards standardisation and quality control on a European level?
10:40 - 11:00 | From Cultivation to Waste Disposal
How is Malta enforcing regulatory procedures?
11:00 - 11:20 | Intellectual Property and its Challenges
How can pharmaceutical companies develop an effective intellectual property and commercial strategy for plant-based products?
11:20 - 11:40 | Traditional Drugs
If Big Pharma doesn't get involved in the medical cannabis industry, what might the financial repercussions be?
11:40 - 12:00 | Synthetic Cannabinoids
What are the benefits and disadvantages of man-made cannabinoids?
12:00 - 12:20 | Social Trends
Medical cannabis is being championed as a natural remedy which can treat a variety of physical and psychological disorders. How might this social shift towards herbal based drugs stack up against the reputation of pharmaceutical companies?
12:20 - 12:40 | Investment and Big Pharma
There's no doubt pharmaceutical companies have the resources to research, develop and market synthetic cannabinoids. With demand exceeding supply in the market how might they use this to carve out their niche in the industry?
12:40 - 13:00 | A Long Process
Pharmaceutical companies have a notoriously long process to get a drug approved. If they move in the direction of synthetic cannabinoids how can they avoid losing out due to the long and expensive timeline?
14:00 - 18:00 | Country Focus Workshop | Australia, New Zealand, Asia, LatAm, United States
INVESTMENT OPPORTUNITIES & THE START-UP PITCH
14:00 - 16:00 | Start-Up Pitch
10 medical cannabis startups with the most innovative projects will pitch on stage in front of established entrepreneurs and savvy investors . Set your sights on the moon and battle it out in a shark-tank environment with some tough love from a select panel of stern judges.
16:00 - 16:20 | From ICO's to Cannabis
Following the recent pitfall that many investors have experienced with ICO's worldwide, could cannabis pave the way for more secure investment opportunities?
16:20 - 16:40 | Market Overview
What is the European medicinal cannabis market worth and what are the future projections?
16:40 - 17:00 | Funding and Research
Both the public and private sector are investing in scientific research. How can the two work together for both the benefit of patients and future commercial success?
17:00 - 17:20 | Mitigating Risk
Investment firms have highlighted several risk factors in investing in the European medical cannabis industry. How are these to be reduced?
17:20 - 17:40 | VC's and PE
Venture capitalists and private equity funds are heavily involved in the North American medical cannabis market. How does this compare to Europe?
17:40 - 18:00 | Going Public
IPO's are happening in Canada. Will the trend move to Europe?
SOCIAL IMPACT, EDUCATION & EUROPE
09:00 - 09:20 | Educating the Public on Medical Cannabis
What sort of public awareness campaigns are needed to destigmatize cannabis and give appropriate information on the options available.
09:20 - 09:40 | Hannah's Story
How did Hannah Deacon push for legislative change in the UK and what has been the outcome of her efforts?
09:40 - 10:00 | Social Impact Studies
What can North American sociological research on the affects of medical cannabis teach European countries?
10:00 - 10:20 | Between Regulation and Education
How can commercial distributors of medicinal cannabis products educate patients without prescribing? What assistance are the medical authorities providing?
10:20 - 10:40 | Marketing and Advertising
Strict regulations are influencing how medical cannabis is marketed. What measures do companies need to take when advertising their products? How will this affect the commercial viability of a business?
10:40 - 11:00 | Investors and Society
As investment firms look for more socially responsible projects to put their money, how is the medical cannabis industry benefiting?
11:00 - 11:20 | The Growth of the European Market
What advantages does Europe have for the development of this embryonic industry.
11:20 - 11:40 | Battle of Jurisdictions
In this animated discussion, legal experts from various jurisdictions will go head to head in explaining which state is leading the way with regulatory innovation.
11:40 - 12:00 | Import and Export
What restrictions do different European manufacturers face in cross-border trade?
12:00 - 12:20 | Towards Self-Sufficiency
Supply of medicinal cannabis products from local suppliers currently outweighs demand in Europe. Is self-sufficiency a realistic goal and what would the timeline be?
12:20 - 12:40 | Insurance Considerations
The EU Parliament has opened up the discussion on whether the public health sector should cover the costs of medical cannabis. What are the benefits and drawbacks and how might the private healthcare insurance sector be effected?
12:40 - 13:00 | Europe-Wide Legislation
What initiatives are in place for the harmonization of medical cannabis laws across Europe?
TECHNOLOGY & SECURITY
14:00 - 14:20 | The Advantages of Blockchain Technology
How will blockchain disrupt this sector and help it to become more lucrative and competitive.
14:20 - 14:40 | Artificial Intelligence
What are the advantages of using AI to predict the size of a producer’s yield and is it financially viable in European markets?
14:40 - 15:00 | Science and Technology
How is cutting edge equipment involved in analytical testing and quality control creating the future of the industry?
15:00 - 15:20 | Bridging the Gap
How is innovative software narrowing the gap between doctor, patient and supplier?
15:20 - 15:40 | Growth and Yield
Effective use of LED lights and innovative growing strategies.
15:40 - 16:00 | Solar Energy
How Malta's medical cannabis industry can benefit from going solar.
16:00 - 16:20 | Large Scale Cultivation
What can Malta learn about security from international growers?
16:20 - 16:40 | Data Protection
Due to the stigma still associated with cannabis, many patients worry about data protection. Which technologies are being used to but their minds at rest?
16:40 - 17:00 | Secure Transportation
What considerations need to be made for the secure transport of crops and finished products within Malta?
17:00 - 17:20 | The Local Insurance Industry
How is the local insurance industry involved with cannabis cultivation facilties, laboratories and retailers?
17:20 - 17:40 | Law Enforcement
The medical cannabis industry is complex. To distinguish between legality and illegality in different parts of the supply chain is important for law enforcement officials. How are they being educated and trained in this area? What can Malta learn from other European countries?
17:40 - 18:00 | Evaluating Medical Cannabis Dispensary Policies
How will this differ in Malta? Is it financially viable to make the required changes?
2018 was the year Malta cemented itself as The Blockchain Island with the launch of Three Bills during the Malta AI & Blockchain Summit last November.
In 2019, the Blockchain Island is moving beyond the hype. The Maltese Government will enact another world first: a Fourth Bill, giving a D.A.O. its own legal personality. In addition, a task force is also working around the clock on a set of incentives that will support businesses in Artificial Intelligence.
We’d like to invite you to stay in Malta an extra few days after the Cannabiz Summit World and attend the Malta AI & Blockchain Summit and engage in riveting discussions about the world changing potential application of such technology.
The Malta AI & Blockchain Summit will take place in the same hotel, back to back with Cannabiz Summit World, making it easier for you to network and grow your business.
Viking PC Health Ltd. is a company registered in Malta, having company registration number C54356 and VAT number MT20561207. Copyright Viking PC Health Ltd. All rights reserved © 2011 – 2019